Fludrocortisone acetate
CAS No. 514-36-3
Fludrocortisone acetate( 9α-fluoro Hydrocortisone Acetate | NSC 15186 | U 4845 )
Catalog No. M14781 CAS No. 514-36-3
Fludrocortisone Acetate is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 32 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 61 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFludrocortisone acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFludrocortisone Acetate is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body.
-
DescriptionFludrocortisone Acetate is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body. It is used to treat Addison's disease by decreasing the amount of sodium that is lost (excreted) in your urine,also used to increase blood pressure.
-
In Vitro——
-
In Vivo——
-
Synonyms9α-fluoro Hydrocortisone Acetate | NSC 15186 | U 4845
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number514-36-3
-
Formula Weight422.5
-
Molecular FormulaC23H31FO6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bragsin2
Bragsin2 is a hydration-resistant cell penetrant, selective and non-competitive inhibitor of Afr guanine nucleotide exchange factor BRAG2.
-
2,6-Dimethoxyphenol
2,6-Dimethoxyphenol is a natural product and can be used for the measurement of laccase activity.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
Cart
sales@molnova.com